Clinical characteristics of 2019 novel coronavirus pneumonia in Zhejiang province, China

Abstract

Since december 2019, an increasing number of cases associated with the 2019 novel coronavirus (2019-ncoV) have emerged in Wuhan, china, which has resulted in a rapid outbreak in china and worldwide. The present study aimed to describe the clinical, laboratory and radiological characteristics of 2019-ncoV pneumonia (ncP) in Zhejiang province, outside of Wuhan. a total of 74 patients with 2019-ncoV were continuously enrolled between January 22 and March 2, 2020 at Zhejiang Hospital. Diagnosis was confirmed at Zhejiang Hospital by reverse transcription-Pcr (rT-Pcr), which was approved by the chinese government. Subsequently, the clinical features between positive-and negative-ncP patients in Zhejiang were compared. among the 74 hospitalized patients with suspected 2019-ncP, six patients (one male and five female patients) were confirmed to be infected with 2019-nCoV by RT-PCR. The average age of the confirmed patients was 40±13 years. There were three family clusters among the confirmed cases, one patient from each of these families had travel history or contact with patients from Wuhan within 2 weeks. compared with non-ncP patients, the most common symptoms at onset for patients with ncP were fever (5/6; 83.3%) and cough (5/6; 83.3%), followed by dyspnea/pharyngalgia (2/6; 33.3%), whereas myalgia (1/6; 16.7%) and fatigue (1/6; 16.7%) were less common. all 74 patients with suspected ncP exhibited abnormal computerized tomography (cT) images. in total, 2/6 (33.3%) patients with confirmed NCP presented with bilateral pneumonia, and 21/68 (30.9%) non-ncP patients exhibited bilateral pneumonia, with bilateral distribution of patchy shadows or ground glass opacity. The present study revealed that epidemiological history was critical to the diagnosis of 2019-ncoV in low epidemic regions outside Hubei province. it was also identified that chest CT could not replace nucleic acid testing due to similar radiological manifestations.

Exploring the impact of COVID-19 on individual's travel mode choice in China

“…Since the first outbreak of the coronavirus disease 2019(COVID-19) in late 2019 in Wuhan, Hubei, China ( Zhang et al, 2020 ; Chen et al, 2020 ), this highly contagious respiratory syndrome had spread quickly to become the most serious issue to public health globally ( Zhou et al ). As of March 16, 2021, the WHO reported that more than 119.9 billion cases have been confirmed worldwide and more than 2.65 million people died (2020a).…”

Analysis of the Geographic Transmission Differences of COVID-19 in China Caused by Population Movement and Population Density

“…The daily reported epidemiological data of these regions are collected through the websites of the Health Commissions or from the literature (Cheng et al. 2020b ; Liu et al. 2020 ).…”

Allergic Airway Inflammation Emerges from Gut Inflammation and Leakage in Mouse Model of Asthma

“…Mouse model of asthma is characterized with AAI developed with i.p OVA sensitization and i.n challenge with OVA in BALB/c mice. This model is characterized by airway inflammation associated with increased type 2 lymphocytes infiltration, eosinophils, alveolar epithelial barrier damage, and mucus secretion by epithelial goblet cells, [2,15,16,32,33] however, the inflammatory manifestations in the gut in not well studied. As observed in several previous studies highlighted the importance of Th2 responses in both gut and lung, we first intend to observe the type of inflammation in the gut and lung at prechallenge and post-challenge conditions during the development of AAI in mouse model of asthma.…”